Product Information
PAROXETINE CR 37.5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.4279 per EA under NDC 60505131803. Its NADAC has been published 306 times since Aug 19, 2020.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
37.5 mg/1
Manufacturer
Apotex Corp.NDC
60505131803
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020936On Market Since
8/9/2019
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE CR 37.5 MG TABLET has been published 306 times since Aug 19, 2020, and over the history we have for it it has declined 75.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4279 per EA |
|---|---|
| All-time high | $1.7299 (Sep 16, 2020) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.4047 |
| Median price | $0.7135 |
| Average price | $0.8222 |
| Largest weekly change | +50.9% (Feb 22, 2023) |
| Weeks tracked | 306 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAROXETINE CR 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE CR 37.5 MG TABLET, manufactured by Apotex Corp., is $0.4279 per EA (NDC 60505131803), effective Jun 24, 2026.
How has the price of PAROXETINE CR 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE CR 37.5 MG TABLET has declined 75.3%. It has been tracked across 306 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for PAROXETINE CR 37.5 MG TABLET?
Since Aug 19, 2020, the NADAC for PAROXETINE CR 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $1.7299 (Sep 16, 2020), with a median of $0.7135 per EA.
Are there cheaper alternatives to PAROXETINE CR 37.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PAROXETINE CR 37.5 MG TABLET, but none are currently priced below it.
Who manufactures PAROXETINE CR 37.5 MG TABLET?
PAROXETINE CR 37.5 MG TABLET (NDC 60505131803) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification